BU SBRP researcher Jennifer Schlezinger (Project 4) recently published a paper titled "An L-Tyrosine Derivative and PPAR Gamma Agonist, GW7845, Activates a Multifaceted Caspase Cascade in Bone Marrow B Cells" in the journal Toxicological Sciences. In this experiment Schlezinger et al. examined the molecular mechanisms of cell death for the drug GW7845 to investigate how PPAR gamma agonists may contribute to tumor killing as well as normal bone marrow B lymphocyte toxicity.

On Tuesday June 19, 2007, Dr. Olaf Paepke will be giving a talk titled "Human Exposure to Brominated Flame Retardants: An International Perspective." The talk will run from 12pm-1pm in R-115 in the BU Medical School Instructional Building. Dr. Paepke is a German chemist who has collaborated with BU SBRP researcher Tom Webster (Project 2) in the past.

BU SBRP researcher David Waxman (Project 3) recently spoke at the 4th Copenhagen Workshop on Endocrine Disrupters held in Copenhagen, Denmark. The meeting is supported by the Danish Ministry of the Environment and focused on "Endocrine disrupters and consumer products: Possible effects on human populations." Dr. Waxman delivered a talk titled "Interactions of Endocrine-active Environmental Chemicals with Nuclear Receptors."

The presentation was co-authored by BU SBRP-supported postdoctoral fellows and students Gargi Bagchi, Jonathan Shipley and Christopher Hurst. Click here to view a PDF of the conference program.

On Wednesday May 30, 2007, BU SBRP researcher Tom Webster (Project 2) and doctoral student Jessica Nelson will be leading a forum titled "Measuring Chemicals in People: Promises and Pitfalls."  The forum will discuss biomonitoring (the practice of measuring chemicals in people's bodies).  As the technology has improved, biomonitoring is increasingly being used by health agencies and advocacy organizations, with California just establishing the first statewide surveillance program. This meeting will provide an overview of biomonitoring -- what it is and how it's being used -- as well as address some of the significant ethical and policy questions raised by this issue.

This forum is sponsored by the Massachusetts Public Health Association's Environmental and Occupational Health Section and the BU SBRP. The forum will be from 6-8pm and be held at the MPHA offices at 434 Jamaicaway, Boston.

For more information, contact This e-mail address is being protected from spambots, you need JavaScript enabled to view it , MPHA: 617-524-6696, ext. 111.